Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.62 |
| ▸ | POLB | P06746 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | SMYD3 | Q9H7B4 | 2/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.52 |
| ▸ | CCR1 | P32246 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34468797 | 1.00 | KDM4E (0.62) | KDM4EPOLBKMT2AALDH1A1SMYD3 | |
| SCHEMBL34468812 | 1.00 | KDM4E (0.62) | KDM4EPOLBKMT2AALDH1A1SMYD3 | |
| SCHEMBL34468746 | 0.90 | KDM4E (0.51) | KDM4EPOLBKMT2AALDH1A1SMYD3 | |
| SCHEMBL34468972 | 0.90 | EGLN1 (0.52) | KDM4EPOLBKMT2AALDH1A1SMYD3 | |
| SCHEMBL34468937 | 0.88 | PADI4 (0.57) | KDM4EPOLBALDH1A1SMYD3HSD17B10 | |
| SCHEMBL34468859 | 0.86 | SMYD3 (0.52) | SMYD3CCR1EGLN1 | |
| SCHEMBL1440740 | 0.86 | SMYD3 (0.57) | KDM4EKMT2AALDH1A1SMYD3HPGD | |
| SCHEMBL6883379 | 0.82 | MEN1 (0.64) | KDM4EKMT2AALDH1A1HPGDLMNA | |
| SCHEMBL19476075 | 0.82 | MEN1 (0.64) | KDM4EKMT2AALDH1A1HPGDLMNA | |
| SCHEMBL17149629 | 0.82 | MEN1 (0.64) | KDM4EKMT2AALDH1A1HPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090571-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260116873-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE INC (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026090571-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260116873-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE INC (US) | 2026-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116873-A1 | APYRASE INHIBITORS | APEH, AP3M1, SRR | KDM4E 2360/4885POLB 3641/4885KMT2A 2697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.